FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,978,000 | -14.4% | 84,000 | +25.4% | 0.06% | -26.3% |
| Q2 2021 | $5,817,000 | +31.1% | 67,000 | +37.3% | 0.08% | -25.5% |
| Q4 2020 | $4,438,000 | +454.8% | 48,800 | +144.0% | 0.10% | +436.8% |
| Q3 2020 | $800,000 | +52.7% | 20,000 | +30.7% | 0.02% | +11.8% |
| Q2 2020 | $524,000 | -84.0% | 15,300 | -89.6% | 0.02% | -90.9% |
| Q1 2020 | $3,281,000 | +19.7% | 147,700 | +5.5% | 0.19% | +102.2% |
| Q4 2019 | $2,740,000 | – | 140,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |